03-32006. Memorandum of Understanding Between the Food and Drug Administration, Department of Health and Human Services of the United States of America and Swissmedic of the Swiss Confederation Regarding Exchange of Information About Pharmaceutical ...  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between the Food and Drug Administration, Department of Health and Human Services of the United States of America and Swissmedic of the Swiss Confederation. The purpose of this MOU is to further enhance and strengthen communication and existing public health promotion and protection cooperative activities related to the regulation of human or animal pharmaceutical products and human medical devices in Switzerland and the United States of America.

    DATES:

    The agreement became effective September 22, 2003.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Naomi Kawin, Office of International Start Printed Page 75578Programs (HFG-1), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-0590.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU.

    Start Signature

    Dated: December 18, 2003.

    Jeffrey Shuren,

    Assistant Commissioner for Policy.

    End Signature

    Start Printed Page 75579

    Start Printed Page 75580

    Start Printed Page 75581

    End Supplemental Information

    BILLING CODE 4160-01-S

    [FR Doc. 03-32006 Filed 12-30-03; 8:45 am]

    BILLING CODE 4160-01-C

Document Information

Effective Date:
9/22/2003
Published:
12/31/2003
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
03-32006
Dates:
The agreement became effective September 22, 2003.
Pages:
75577-75581 (5 pages)
Docket Numbers:
FDA 225-04-8004
PDF File:
03-32006.pdf